1. Home
  2. SAGE vs WDH Comparison

SAGE vs WDH Comparison

Compare SAGE & WDH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SAGE
  • WDH
  • Stock Information
  • Founded
  • SAGE 2010
  • WDH 2016
  • Country
  • SAGE United States
  • WDH China
  • Employees
  • SAGE N/A
  • WDH N/A
  • Industry
  • SAGE Biotechnology: Pharmaceutical Preparations
  • WDH Specialty Insurers
  • Sector
  • SAGE Health Care
  • WDH Finance
  • Exchange
  • SAGE Nasdaq
  • WDH Nasdaq
  • Market Cap
  • SAGE 474.6M
  • WDH 564.5M
  • IPO Year
  • SAGE 2014
  • WDH 2021
  • Fundamental
  • Price
  • SAGE $7.77
  • WDH $1.45
  • Analyst Decision
  • SAGE Hold
  • WDH
  • Analyst Count
  • SAGE 19
  • WDH 0
  • Target Price
  • SAGE $9.88
  • WDH N/A
  • AVG Volume (30 Days)
  • SAGE 1.2M
  • WDH 446.2K
  • Earning Date
  • SAGE 04-24-2025
  • WDH 03-12-2025
  • Dividend Yield
  • SAGE N/A
  • WDH 2.47%
  • EPS Growth
  • SAGE N/A
  • WDH 150.00
  • EPS
  • SAGE N/A
  • WDH 0.14
  • Revenue
  • SAGE $41,243,000.00
  • WDH $379,748,325.00
  • Revenue This Year
  • SAGE $100.39
  • WDH N/A
  • Revenue Next Year
  • SAGE $70.86
  • WDH $10.19
  • P/E Ratio
  • SAGE N/A
  • WDH $10.66
  • Revenue Growth
  • SAGE N/A
  • WDH 5.36
  • 52 Week Low
  • SAGE $4.62
  • WDH $0.97
  • 52 Week High
  • SAGE $17.51
  • WDH $1.57
  • Technical
  • Relative Strength Index (RSI)
  • SAGE 48.49
  • WDH 54.35
  • Support Level
  • SAGE $7.99
  • WDH $1.27
  • Resistance Level
  • SAGE $8.81
  • WDH $1.54
  • Average True Range (ATR)
  • SAGE 0.31
  • WDH 0.11
  • MACD
  • SAGE -0.06
  • WDH -0.01
  • Stochastic Oscillator
  • SAGE 9.57
  • WDH 60.00

About SAGE Sage Therapeutics Inc.

Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.

About WDH Waterdrop Inc. (each representing the right to receive 10)

Waterdrop Inc is a technology platform dedicated to insurance and healthcare service. It is a third-party insurance platform in China in terms of life and health insurance.

Share on Social Networks: